Avidity Partners Management LP

Position in CATX — Perspective Therapeutics, Inc.

CIK 1791827 DALLAS, TX

Position in CATX

as of Mar 31, 2026 · filed May 28, 2026 Compact

Position Value

$25,228,495

+$16,398,980 QoQ

Shares Held

6,049,999

+88.4% QoQ

Ownership

5.30%

of shares outstanding

% of Portfolio

5.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Avidity Partners Management LP holds $46,435,595 across 6 Medical Devices names. CATX ranks #1 (54.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CATX	Perspective Therapeutics, Inc. This page	6,049,999	$25,228,495
2	MDT	Medtronic plc	100,000	$8,665,000
3	DXCM	Dexcom Inc	90,000	$5,652,000
4	BSX	Boston Scientific Corp	60,000	$3,765,000
5	PODD	Insulet Corp	10,000	$2,098,400
6	ABT	Abbott Laboratories	10,000	$1,026,700

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$25,228,495	6,049,999	0.0%	Shares	Sole	2026-05-28
2026-02-20	$34,182,494	6,049,999	+88.4%	Shares	Sole	2026-03-10
2025-12-31	$8,829,515	3,210,733	+7.2%	Shares	Sole	2026-02-13
2025-09-30	$10,269,533	2,994,033	+61.1%	Shares	Sole	2025-11-14
2025-06-30	$6,393,570	1,858,596	-15.4%	Shares	Sole	2025-08-14
2025-03-31	$4,680,185	2,197,270	-18.5%	Shares	Sole	2025-05-15
2024-12-31	$8,595,774	2,694,600	-5.2%	Shares	Sole	2025-02-14
2024-12-31	$9,062,866	2,841,024	-17.5%	Shares	Sole	2025-02-14
2024-09-30	$45,977,426	3,444,002	+13.4%	Shares	Sole	2024-11-14
2024-06-30	$30,285,549	3,037,668	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.